drugset / Trial / NCT04318145
Study to Evaluate Sex Differences in the Acute Effects of PL-3994 in Heart Failure Subjects
Non-randomizedSingle-groupOpen-labelTreatment
Summary
A Multi-Center, Unblinded, Single-Arm Study to Evaluate Sex Differences in the Acute Effects of PL-3994 on Myocardial cGMP Enhancement and Hemodynamics in Heart Failure with Preserved Ejection Fraction
Timeline
- Start
- 2020-11-12
- Primary completion
- 2023-12-08
- Completion
- 2023-12-08
Outcome
Outcome not reported
Stopped (Enrollment): “Study cancelled after Part A. Enrollment taking too long.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PL-3994 | Protein / enzyme biologic | — | Intravenous |